Shifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseases
dc.contributor.author | de Souza, D.K. | |
dc.contributor.author | Dadzie, S. | |
dc.contributor.author | Osei, J.H.N. | |
dc.contributor.author | Boakye, D.A. | |
dc.contributor.author | Suzuki, T. | |
dc.date.accessioned | 2019-01-22T10:21:54Z | |
dc.date.available | 2019-01-22T10:21:54Z | |
dc.date.issued | 2012-12 | |
dc.description.abstract | Genetically modified (GM) vectors offer an opportunity for the control of many infectious diseases including malaria and dengue. However, they face issues of ethical consent, public and social acceptance and environmental concerns. Thus, strategies are needed to address these concerns before GM mosquitoes could be openly released. One example, the use of GM mosquitoes as "Flying Vaccinators" that have been designed to produce vaccine candidates, may provide some solutions to the concerns raised against GM vectors. | en_US |
dc.identifier.other | Vol. 20(4): pp 117 | |
dc.identifier.uri | http://ugspace.ug.edu.gh/handle/123456789/26969 | |
dc.language.iso | en | en_US |
dc.publisher | Asia-Pacific Journal of Molecular Biology and Biotechnology | en_US |
dc.subject | Flying vaccinators | en_US |
dc.subject | Genetically modified mosquitoes (GMM) | en_US |
dc.subject | Infectious diseases | en_US |
dc.title | Shifting the focus from open release of genetically modified mosquitoes, to controlled individualized treatment for infectious diseases | en_US |
dc.type | Other | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.6 KB
- Format:
- Item-specific license agreed upon to submission
- Description: